Dr. Aggarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
70 Francis St
Boston, MA 02115Phone+1 617-667-7000
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2019 - 2022
Boston University School of MedicineClass of 2019
Certifications & Licensure
MA State Medical License 2019 - 2026
American Board of Internal Medicine Internal Medicine
Clinical Trials
- ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2021 Jan 26
Publications & Presentations
PubMed
- Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.Rahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton
Journal of the American Heart Association. 2025-03-04 - Prevalence and Control of Diabetes Among US Adults, 2013 to 2023.Kosuke Inoue, Michael Liu, Rahul Aggarwal, Lucas X Marinacci, Rishi K Wadhera
JAMA. 2025-02-27 - Prevalence of Chronic Medical Conditions Among Medicare Advantage and Traditional Medicare Beneficiaries.Andrew S Oseran, Rahul Aggarwal, Jose Figueroa, Karen E Joynt Maddox, Bruce E Landon
Annals of Internal Medicine. 2025-02-25
Press Mentions
Empagliflozin Confers Kidney-Protective Benefits After Acute MISeptember 10th, 2024- What You Need to Know About CKM, the Link Between Heart Health, Diabetes and Kidney DiseaseMay 19th, 2024
- Diabetes Often Leads to Heart and Kidney Disease, TooMay 15th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
